ClinicalTrialsFinder
RecruitingPhase 2NCT07547995

A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis.

A Phase II Clinical Study to Assess the Efficacy and Safety of GenSci048 in Subjects With Active Non-infectious Uveitis.

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.

Enrollment

74 participants

Start Date

Jun 29, 2026

Study Type

INTERVENTIONAL

Conditions

Uveitis

Summary

This study is designed to evaluate the efficacy and safety of GenSci048 compared with placebo in subjects with active non-infectious uveitis.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called GenSci048 and a drug called Placebo for people with uveitis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGGenSci048

Administered SC.

DRUGPlacebo

Administered SC.

Locations(1)

Eye & Ent Hospital of Fudan University

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07547995

Related Trials

PANDA-ASOCT: Paediatric Anterior Uveitis Detection With Automated Image Analysis Using ASOCT

NCT07813598

Metagenomics for Ocular Inflammation

NCT069741621 location

A Study of Uveitis in Children <18 Years of Age

NCT075181344 locations

RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age

NCT0627374819 locations

Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography

NCT017465371 location